Literature DB >> 2897447

Inhibition of the cataleptic effect of tetrahydrocannabinol by other constituents of Cannabis sativa L.

E A Formukong1, A T Evans, F J Evans.   

Abstract

Tetrahydrocannabinol (THC) induced catalepsy in mice, whereas a cannabis oil (6.68% w/w THC), four cannabinoids and a synthetic mixture did not. Cannabinol (CBN) and olivetol inhibited THC-induced catalepsy in the mornings and the evenings, but cannabidiol (CBD) exhibited this effect only in the evenings. A combination of CBN and CBD inhibited THC-induced catalepsy equal to that of CBN alone in the mornings, but this inhibition was greater than that produced by CBN alone in the evenings.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2897447     DOI: 10.1111/j.2042-7158.1988.tb05198.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  5 in total

Review 1.  Cannabinoids in clinical practice.

Authors:  E M Williamson; F J Evans
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

2.  Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism.

Authors:  T D M Hill; M-G Cascio; B Romano; M Duncan; R G Pertwee; C M Williams; B J Whalley; A J Hill
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

3.  Single and combined effects of Δ9 -tetrahydrocannabinol and cannabidiol in a mouse model of chemotherapy-induced neuropathic pain.

Authors:  Kirsten M King; Alyssa M Myers; Ariele J Soroka-Monzo; Ronald F Tuma; Ronald J Tallarida; Ellen A Walker; Sara Jane Ward
Journal:  Br J Pharmacol       Date:  2017-07-27       Impact factor: 8.739

4.  Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors.

Authors:  T V Zanelati; C Biojone; F A Moreira; F S Guimarães; Sâmia R L Joca
Journal:  Br J Pharmacol       Date:  2009-12-04       Impact factor: 8.739

5.  Analgesic and antiinflammatory activity of constituents of Cannabis sativa L.

Authors:  E A Formukong; A T Evans; F J Evans
Journal:  Inflammation       Date:  1988-08       Impact factor: 4.092

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.